Overview

Bevacizumab and Retinal Vascular Occlusions

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the effects of Intravitreal Bevacizumab in macular edema in retinal vascular occlusion.
Phase:
Phase 3
Details
Lead Sponsor:
Asociación para Evitar la Ceguera en México